Anti-viral T-cell Therapy(University Of Pittsburgh)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameAnti-viral T-cell Therapy(University Of Pittsburgh)
Drug Alias NameSpecific T- Lymphocytes cell Therapy(University Of Pittsburgh)Viral Specific T-Lymphocytes cell Therapy(University Of Pittsburgh)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Virus-specific T Cell therapyCell and gene therapy > Cell therapy > Source of cells > PMBC-derived
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus InfectionsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus InfectionsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A